This study investigates the R&D risk choices in a differentiated duopoly, in which a firm has partial passive ownership holdings (P.P.O.s) in its rival. Firms perform R&D projects with identical expected outcomes but different risk degrees. It mainly finds that:
No takes yet. Share an insight, caveat, or question.
Xing et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: